Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Aristeia Capital, L.L.C. | 319.5K | -- | 0.57% | -- | 2026-06-30 |
| Linden Advisors LP | 268.2K | -- | 0.48% | -- | 2026-06-30 |
| Saba Capital Management, L.P. | 233.8K | -- | 0.42% | -- | 2026-06-30 |
| Moore Capital Management, LP | 125.0K | -- | 0.22% | -- | 2026-06-30 |
| Polar Asset Management Partners Inc. | 122.7K | -- | 0.22% | -- | 2026-06-30 |
| MMCAP International Inc. SPC | 111.7K | -- | 0.20% | -- | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 83.4K | -- | 0.15% | -- | 2026-06-30 |
| Millennium Management LLC | 70.6K | -- | 0.13% | -- | 2026-06-30 |
| Blue Owl Capital Holdings LP | 50.0K | -- | 0.09% | -- | 2026-06-30 |
| Toronto Dominion Bank | 35.1K | -- | 0.06% | -- | 2026-06-30 |
